Local veterinarians see increase in pet poisonings from marijuana, medications as owners urged to treat homes like they have ...

Statins protect the heart, but research shows they may cause significant medication nutrient depletion of CoQ10 - and what ...

Research presented at the American Society of Clinical Oncology meeting suggests that popular GLP-1 weight loss and diabetes drugs may lower cancer risks and improve treatment outcomes in patients.

Glucagon-like peptide-1 (GLP-1) receptor agonist medications have gained widespread attention for effectively treating obesity, lowering blood sugar and decreasing the risk of cardiovascular disease.

Semaglutide slowed biological aging across multiple epigenetic clocks in a randomized, double-blind, placebo-controlled ...

Noninvasive mapping with hundreds of body surface electrodes transforms the inverse ECG problem, letting AI and models infer intracardiac activation without catheter insertion.

Learn how the Samsung Galaxy Watch supports diabetes management through Samsung Health, blood sugar logs, medication tracking ...

Background Shorter dual antiplatelet therapy (DAPT) regimens may offer a more favourable risk-benefit profile compared with longer treatment. The aim of this study was to determine the optimal ...

The heart failure (HF) treatment landscape continues to evolve rapidly in 2026, with emerging evidence pointing toward a ...

Health Secretary Robert F. Kennedy Jr. announced an initiative last week to reduce the overprescribing of psychiatric medications, especially among children. In what’s being called a national ...

When cancer spreads to the heart, something odd happens. The lesions that land there tend to stay smaller than the same cancer growing in the liver, the lung, or anywhere else. Oncologists have ...